SAN DIEGO (AP) — SAN DIEGO (AP) — Arcturus Therapeutics (ARCT) on Thursday reported a loss of $27 million in its first quarter.
The San Diego-based company said it had a loss of 95 cents per share.
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.14 per share.
The pharmaceutical company posted revenue of $2.1 million in the period, missing Street forecasts. Five analysts surveyed by Zacks expected $7.9 million.
Arcturus Therapeutics shares have risen 45% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $8.90, a drop of 19% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARCT at https://www.zacks.com/ap/ARCT
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
